DesignMedix

PharmaceuticalsAngelPortland, USdesignmedix.com

Latest round

Angel

Last raised

Jul 2014

Total raised

$3.2M

Investors

5

About DesignMedix

Based in Oregon, DesignMedix is a drug development company which develops drugs to overcome drug resistance in malaria. The firm was founded in 2006.

Who invested in DesignMedix

5 investors across 5 rounds

See all investors in DesignMedix

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Angel

    Jul 18, 2014

    Amount

    $1.5M

    Investors

    Locked

  2. Series B

    Jul 16, 2013

    Amount

    $0.5M

    Investors

    Locked

  3. Series A

    Jun 14, 2010

    Amount

    $0.1M

    Investors

    Locked

  4. Series A

    Apr 13, 2009

    Amount

    $0.3M

    Investors

    Locked

  5. Series A

    Oct 20, 2008

    Amount

    $0.8M

    Investors

    Locked

Questions about DesignMedix

Who invested in DesignMedix?

DesignMedix has 5 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has DesignMedix raised?

DesignMedix has raised 5 venture rounds. Sign up free to see how much each round raised and the total.

When did DesignMedix last raise money?

DesignMedix's most recent round on record is a Angel, in Jul 2014.

What does DesignMedix do?

Based in Oregon, DesignMedix is a drug development company which develops drugs to overcome drug resistance in malaria.

Where is DesignMedix headquartered?

DesignMedix is headquartered in Portland, US.

Which VCs invest in companies like DesignMedix?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at DesignMedix's stage. Their profiles are linked below.

Raising like DesignMedix? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.